• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Tuesday, December 5, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Study of traditional medicine finds high use in Sub-Saharan Africa despite modern medicine

Bioengineer by Bioengineer
December 18, 2018
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers who have undertaken the first systematic review of into the use of traditional, complementary and alternative medicines (TCAM) in Sub-Saharan Africa found its use is significant and not just because of a lack of resources or access to “conventional medicine”.

Researchers from the Australian Research Centre in Complementary and Integrative Medicine (ARCCIM) at the University of Technology Sydney (UTS) in Australia conducted what they say is the first empirical study into TCAM in the region. The paper “Traditional, complementary and alternative medicine use in Sub-Saharan Africa: a systematic review”, in the journal BMJ Global Health, looked at 180 studies on TCAM use in the region between 2006 and 2017.

“Health departments and governments across the region must acknowledge that TCAM is here to stay and seek to understand the challenges and opportunities this presents for health care,” says University of Sierra Leone lecturer and UTS doctoral candidate Peter Bai James, who led the study.

Their review found relatively high use of TCAM alone, or in combination with conventional medicine, in the general population and for specific health conditions such as pregnancy, cancer and malaria.

TCAM use – especially TCAM products – was “significant”, the researchers found, with up to 94% of the population in Nigeria and Ethiopia and an average of just under 60% across the studies. The researchers acknowledged the available articles came from just four countries and were not always of the highest quality, highlighting the need for further public health research in this area.

Biological-based therapies such as herbal therapy were the most common TCAM used in Sub-Saharan Africa, followed by faith-based healing methods (prayer/spirituality) and mind-body therapies (massage, traditional bone setting, relaxation, meditation and yoga).

“TCAM is used due to its perceived low cost, alignment … with sociocultural, religious and spiritual values, and dissatisfaction with conventional health-care,” the researchers say.

Users in the general population were found to be more likely to be of low socioeconomic and educational status.

Most users failed to disclose their use of these medicines to their health-care providers because they feared they would receive improper care as a result, because of health-care providers’ negative attitudes to TCAM, and because health-care providers didn’t inquire.

The review indicated a relatively low prevalence of self-reported adverse effects compared with that reported outside Africa, but the researchers noted this might be related to the tendency not to disclose use.

“TCAM product safety regulation across Africa is still a challenge as many countries … lack adequate regulatory framework to ensure the safety and quality of TCAM,” the paper says. “The systematic collection and analysis of TCAM safety data is crucial in order to protect patients and the public at large.”

Leading author Peter Bai James of ARCCIM at UTS says discussions around TCAM use globally are often based on assumptions.

“Assumptions about use in Sub-Saharan African have shaped lots of existing WHO and NGO policy,” he says, and among those assumptions is the belief that its use is because of poor access to “conventional medicine”.

“But our research shows that even as conventional health services become more prevalent, TCAM use also increases,” he says.

“TCAM is often an afterthought in health policy discussions in Sub-Saharan Africa and that should not be the case. Our research has highlighted the critical role TCAM continues to play in providing primary healthcare across the continent.

“TCAM use in Sub-Saharan Africa is here to stay. Health departments and governments across the region must recognise this and conduct further research to understand the role of TCAM within their populations and consider the challenges and opportunities of TCAM within the wider health-care system.”

###

Media Contact
Peter James
[email protected]
61-416-175-256

Related Journal Article

https://www.uts.edu.au/research-and-teaching/our-research/complementary-and-integrative-medicine/news/traditional-and
http://dx.doi.org/10.1136/bmjgh-2018-000895

Tags: Alternative MedicineBehaviorcancerDisease in the Developing WorldMedicine/HealthPublic Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Mutated protein associated to recycling regulation

Leukemia cells activate cellular recycling program

December 4, 2023
Highly aggressive cell carcinomas

Mathematics supporting fresh theoretical approach in oncology

December 4, 2023

Training the immune system to prevent cancer – NextGen researchers discover paradigm-shifting approach

December 4, 2023

Immunotherapy added to first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

December 4, 2023
Please login to join discussion

POPULAR NEWS

  • Figure 1

    Understanding rapid tendon regeneration in newts may one day help human athletes

    85 shares
    Share 34 Tweet 21
  • Study finds increasingly popular oral nicotine pouches do little to curb smokers’ cravings

    35 shares
    Share 14 Tweet 9
  • SMART researchers pioneer novel microfluidic method to optimise bone marrow stem cell extraction for advanced cell therapies

    34 shares
    Share 14 Tweet 9
  • UMass Amherst receives $2.5 million from Howard Hughes Medical Institute to reshape STEM education

    34 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Recycling concrete using carbon can reduce emissions and waste

Powerful financial giants could play vital role in preventing the next pandemic

Wildfires have erased two decades’ worth of air quality gains in western United States

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 58 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In